John B. Whelan
2011
In 2011, John B. Whelan earned a total compensation of $5.9M as Former President and Chief Executive Officer; current Chief Financial Officer at Heron Therapeutics, a 782% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $197,500 |
|---|---|
| Option Awards | $5,357,835 |
| Salary | $354,231 |
| Other | $7,350 |
| Total | $5,916,916 |
Whelan received $5.4M in option awards, accounting for 91% of the total pay in 2011.
Whelan also received $197.5K in non-equity incentive plan, $354.2K in salary and $7.4K in other compensation.
Rankings
In 2011, John B. Whelan's compensation ranked 841st out of 10,747 executives tracked by ExecPay. In other words, Whelan earned more than 92.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 841 out of 10,747 | 92nd |
Division Manufacturing | 307 out of 3,960 | 92nd |
Major group Chemicals And Allied Products | 71 out of 1,033 | 93rd |
Industry group Drugs | 38 out of 781 | 95th |
Industry Pharmaceutical Preparations | 33 out of 571 | 94th |
Source: SEC filing on May 9, 2013.
Whelan's colleagues
We found one more compensation record of an executive who worked with John B. Whelan at Heron Therapeutics in 2011.
2011
Michael Adam
Heron Therapeutics